Skip to main content
SpringerLink
Log in

Future Source of Allogeneic Stem Cells: Bone Marrow or Peripheral Blood?

  • Chapter
Book cover Transplantation in Hematology and Oncology

  • 98 Accesses

Abstract

The main source of cells for transplantation and engraftment of the hematopoietic system is bone marrow, but other sources of such cells include peripheral blood, umbilical blood and fetal liver.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Apperley J, Gluckman E, Gratwohl A, Craddock C (eds). Blood and Marrow Transplantation. EBMT Handbook 1998

    Google Scholar 

  2. Beelen DW et al. (1997) Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism. Blood 90:4725–4735

    PubMed  CAS  Google Scholar 

  3. Beelen DW et al. (1998) A single center prospective comparison of allogeneic peripheral blood stem cell transplantation (PBSCT) and bone marrow transplantation (BMT) in adult patients (PTS) with hematologic malignancies. In: Annals of Hematology 77 (Suppl II). Springer, p 74

    Google Scholar 

  4. Elmaagacli AH et al. (1998) Allogeneic peripheral blood stem cell transplantation (PBSCT) is associated with less frequent detection of minimal residual disease (MRD) and a lower relapse rate compared to bone marrow transplantation (BMT) in patients with chronic myelogenous leukemia (CML) in chronic phase (CP). In: Annals of Hematology 77 (Suppl II). Springer, p 172

    Google Scholar 

  5. Levitt D, Mertelsmann R (1995) Hematopoietic stem cells. M. Dekker, New York

    Google Scholar 

  6. Ottinger HD et al. (1996) Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88:2775–2779

    PubMed  CAS  Google Scholar 

  7. Schmitz N et al. (1997) Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 21, p 995–1003

    Article  Google Scholar 

  8. Slavin Sh et al (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91:756–763

    PubMed  CAS  Google Scholar 

  9. Winter JN (1997) Blood stem cell transplantation. Kluwer, Norwell/USA

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Knochenmarktransplantation, Universitätsklinikum Essen, Hufelandstraße 55, D-45122, Essen, Germany

    U. W. Schaefer

Authors
  1. U. W. Schaefer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal Medicine Hematology/Oncology, University of Muenster, Albert-Schweitzer-Straße 33, 48129, Muenster, Germany

    W. E. Berdel (Prof. Dr. med.), Th. Büchner (Prof. Dr. med.), J. Kienast  & J. Van De Loo (Prof. Dr. med.) (Prof. Dr. med.),  (Prof. Dr. med.),  &  (Prof. Dr. med.)

  2. Department of Pediatrics, University of Münster, Albert-Schweitzer-Straße 33, 48129, Muenster, Germany

    H. Jürgens (Prof. Dr. med.), J. Ritter (Prof. Dr. med.) & J. Vormoor (Dr. med.) (Prof. Dr. med.),  (Prof. Dr. med.) &  (Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schaefer, U.W. (2000). Future Source of Allogeneic Stem Cells: Bone Marrow or Peripheral Blood?. In: Berdel, W.E., et al. Transplantation in Hematology and Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59592-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59592-9_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64041-4

  • Online ISBN: 978-3-642-59592-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation